In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Guidant: The New Rules of the Device Game

Executive Summary

As it seeks to capitalize on new opportunities in both its CRM and interventional businesses, Guidant also confronts a device industry whose rules are changing. The second of a two-part series.
Advertisement

Related Content

From Guidant to Abbott: An Interview with John Capek
How To Fix A Guidant: Boston Scientific's Tobin Opens Playbook
Biosensors: Small Company Turns Major Dealmaker
Guidant Shines Light on Vulnerable Plaque with Miravant Deal
Cameron Health and the Revolution From Below
Next Drug Stent Trials: Medtronic Goes to Europe, Guidant Stays Home
Convergent Calling: An Interview with Medtronic's Stephen Oesterle
Guidant's Loss of Innocence
Guidant's Loss of Innocence
Growing Companies--Part II

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002159

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel